OncoMark Ltd. is a private company centred on the development and application of biomarker panels, particularly supporting oncology drug development. A major focus of the company is to provide the link from -omic level discovery to validation via the use of multiplex antibody-based assays and high-throughput tissue microarray screening. OncoMark also conducts in-house research and development to (1) create unique multi-marker assays for use in the discrimination of patient response to drug therapies and (2) apply novel in-house image analysis toolkit for assessment of IHC-based markers at the subcellular compartmental level [IHC-MARK]. This is of particular benefit to the pharmaceutical and health authority sectors.
Location: Ireland, Leinster, Dundrum
Member count: 11-50
Total raised: $2.226701M
Founded date: 2007
Investors 2
| Date | Name | Website |
| - | Irrus Inve... | irrusinves... |
| - | Halo Busin... | hban.org |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 15.02.2017 | - | $2.226701M | - | finsmes.co... |
Mentions in press and media 2
| Date | Title | Description | Category | Author | Source |
| 15.02.2017 | UCD Spinou... | UCD spinout OncoMark has annou... | - | - | businesspl... |
| 15.02.2017 | OncoMark S... | Pictured were Dawn Walsh, Kern... | Ireland | - | finsmes.co... |